Old Web
English
Sign In
Acemap
>
authorDetail
>
Shyamal A. Balki
Shyamal A. Balki
Medicine
Psoriasis
Dermatology
Secukinumab
Regimen
3
Papers
129
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
27346 Efficacy and safety from a phase II study of AUR101, a RORγ inhibitor in moderate-to-severe psoriasis (INDUS-2)
2021
Journal of The American Academy of Dermatology
Divyesh Mandavia
Sushil Pande
Suneel Vartak
Shyamal A. Balki
Shilendra Pandey
Sanjeev Giri
Muralidhara Ramachandra
Show All
Source
Cite
Save
Citations (0)
Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)
2015
Journal of The American Academy of Dermatology
Ulrich Mrowietz
Craig L. Leonardi
Giampiero Girolomoni
Darryl Toth
Akimichi Morita
Shyamal A. Balki
Jacek C. Szepietowski
Pascaline Regnault
Helen Thurston
Charis Papavassilis
Show All
Source
Cite
Save
Citations (129)
Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)
2015
Journal of The American Academy of Dermatology
Ulrich Mrowietz
Craig L. Leonardi
Giampiero Girolomoni
Darryl Toth
Akimichi Morita
Shyamal A. Balki
Jacek C. Szepietowski
Pascaline Regnault
Helen Thurston
Charis Papavassilis
Show All
Source
Cite
Save
Citations (0)
1